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ABSTRACT
Objective: Numerous plants have exciting pharmaceutical activities, but Aloe vera (AV) is likely to have many medicinal applications worldwide. 
Therefore, the present study focused on identifying the potential of AV aqueous extract to protect against complications of diabetes.
Methods: Fifty rats were divided into five groups. The first group, the normal group, received a vehicle solution. The second group, the AV group, 
received AV aqueous extract (1/2 ml/100 g body weight). The third group was the streptozotocin (STZ)-induced diabetic rat group (i.p. as a single 
dose), the fourth group was the ameliorative group (a week after STZ injection, rats were given the same daily oral dose of AV extract), and the fifth 
group was the protective group (rats were treated with the same dose of AV extract for 21 days, and on the 14th day after the start of AV treatment, 
STZ injection was performed). At the end of the experiment, changes in serum indices, such as insulin, glucose, aspartate transaminase (AST), alanine 
transaminase (ALT), urea and creatinine, and tissue antioxidants as well as histopathological alterations in the pancreas, liver, and kidney were 
evaluated.
Results: We found that STZ-treated animals displayed significant increases in tissue lipid peroxidation (LPO, as an indicator of oxidative stress), 
serum glucose, AST, ALT, urea, and creatinine, with a parallel decrease in the levels of serum insulin and tissue antioxidants. In accordance with these 
data, several histopathological alterations in the selected organs were observed. When diabetic animals received 1/2 ml/100 g body weight of AV 
extract, these deleterious effects were ameliorated.
Conclusion: In the current study, AV aqueous extract exhibited an ameliorative and protective effect against the oxidative damage and the associated 
complications that occurred in different rat organs due to diabetes mellitus induced by STZ.
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INTRODUCTION
Diabetes mellitus is a metabolic disorder characterized by chronic 
hyperglycemia resulting from defects in the secretion of insulin, the 
activity of insulin, or both [1]. Streptozotocin (STZ) is a chemical 
compound that has selective toxicity toward pancreatic beta cells. It is 
utilized to treat certain cancers of the islets of Langerhans and in medical 
research to induce type 1 and type 2 diabetes in animal models [2]. Lipid 
peroxidation (LPO) induced by free radical generation has been related 
to diabetes and other diseases. Furthermore, STZ-induced diabetes 
has been confirmed to release free radicals and exhibits most of the 
diabetic problems, namely, myocardial, cardiovascular, gastrointestinal, 
nervous, vas deferens, kidney, and urinary bladder dysfunction that are 
mediated through oxidative stress [3].
The liver is an organ that sustains a severe injury in diabetes, and 
hepatic impairment is a major complication of diabetes [4,5]. Oxidative 
stress has been emphasized among the various mechanisms suggested 
for the pathogenesis of diabetic problems, such as renal and hepatic 
tissue damage [6-8]. The biochemical changes that occur in diabetes 
mellitus are exactly like those in liver diseases [9]. The most important 
indicators associated with liver injury are the levels of plasma 
alanine transaminase (ALT), aspartate transaminase (AST), alkaline 
phosphatase, and γ-glutamyltranspeptidase [10,11]. Diabetes mellitus 
affects renal tissues, leading to diabetic nephropathy, which is a 
dysfunction of the kidney characterized by specific renal morphological 
and functional alterations [12].
Available treatments for controlling diabetes and its problems have 
various side effects with limited benefits; thus, the desire for herbal 
products with antidiabetic properties and few side effects that are 
also more cost effective is increasing [13]. The use of herbal medicine 
over many decades has proven its brilliant future in the treatment of 
diabetes. Families of plants such as Leguminosae, Liliaceae, Asteraceae, 
Cucurbitaceae, and many others are commonly used. These plants 
possess antidiabetic efficacy because they contain polyphenols, 
alkaloids, coumarins, saponins, fibers, and other phytoconstituents, 
which significantly decrease blood glucose [14]. The Aloe vera (AV) plant 
(synonym: Aloe barbadensis Miller) belongs to the Liliaceae family, has 
yellow flowers and grows in dry climates [15], and it has been utilized 
for medicinal purposes. Most treatment items are produced from AV gel 
and contain 75 active compounds: vitamins, enzymes, minerals, sugars, 
lignin, saponins, salicylic acids, and amino acids [16]. In the present 
investigation, the ameliorative and protective impacts of AV have been 




The AV leaves used for this investigation were acquired from the 
research unit at Aswan University for the study of arid land plants. The 
plant was identified and authenticated by the Department of Botany, 
Aswan University, Egypt.
Preparation of AV aqueous extract
Fresh succulent leaves of AV were collected. The inner gel component 
was extracted, homogenized in an electric blender, lyophilized and 
stored at 4°C [17].
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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Chemicals
STZ was purchased from Biovision Co. Egypt; a rat insulin enzyme-
linked immunosorbent assay kit was purchased from Thermo Scientific 
Co.; superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase 
(GPx), and malondialdehyde (MDA) assay kits were purchased from 
Biodiagnostic Co. Egypt.
Experimental animals
Fifty male Wistar rats (weighing 100 ± 20 g) were obtained from 
the animal house in the Faculty of Science at South Valley University. 
Animals were housed in well-ventilated clean cages maintained under 
a 12 h:12 h light: dark cycle at 25 ± 2°C with a relative humidity of 50 ± 
5%. Rats were held for approximately 2 weeks before the study began 
for acclimatization. The animals had access to a pellet diet and water 
ad libitum. Care of the animals and experimental procedures were 
approved by the Animal Ethical Committee of Aswan University, Egypt, 
in accordance with the guide for the care and use of laboratory animals.
Experimental design
Fifty rats were grouped into five equal groups comprising ten animals each:
• Group I: Served as the normal group and the rats received the vehicle 
solution (sodium citrate buffer) only
• Group II: Served as the AV group and rats were treated daily with an 
oral dose (1/2 ml/100 gmb. w) [18] of aqueous extract of AV
• Group III: Served as the STZ group and rats were treated with a 
single i.p. injection of 1% STZ at 55 mg/kg b. w. [19]. Animals were 
permitted to drink 5% glucose solution overnight to overcome the 
drug-induced hypoglycemia. After 1 week, fasting blood glucose 
levels were measured using an AccuChek glucometer (Manufacturer: 
Schiffgraben 41, 30175 Hannover, Germany). The rats with blood 
glucose levels above 250 mg/dl were considered diabetic rats and 
utilized for the experiment [20]
• Group IV: Served as an ameliorative group, rats were given a single 
i.p. injection of 1% STZ (55 mg/kg b. w.), and after 1 week, they were 
given a daily oral dose of AV leaf gel extract (1/2 ml/100 gmb. w.) 
[18] for 21 successive days
• Group V: Served as a protective group, and rats were given a daily oral 
dose of AV leaf gel extract (1/2 ml/100 gm b. w.) for 21 successive 
days. On the 14th day, after the start of AV treatment, they received 
a single i.p. injection of 1% STZ (55 mg/kg b. w.).
The animals were sacrificed 24 h after the end of the experimental 
period (21 days).
Blood sampling and serum preparation
After the last dose, animals were sacrificed, blood samples were 
collected in dried centrifuge tubes, and serum was separated by 
centrifugation at 3000 rpm for 15 min at room temperature. Serum was 
collected carefully and kept at −20°C. Concentrations of serum insulin, 
blood glucose, aspartate transaminase (AST), alanine transaminase 
(ALT), urea, creatinine, Low-density lipoprotein (LDL)-cholesterol, 
and triglycerides were assayed according to the manufacturer’s 
instructions.
Estimation of insulin and glucose
Blood samples were collected in heparinized and dried centrifuge 
tubes, and serum was separated by centrifugation at 3000 rpm for 
15 min at room temperature and kept at −20°C for the estimation of 
serum concentrations of insulin and glucose according to Manley 
et al. [21] and O-toluidine method [22], respectively.
Estimation of serum aspartate transaminase (AST) and alanine 
transaminase (ALT) concentrations
AST and ALT were estimated at the endpoint by a colorimetric method [23].
Determination of urea and creatinine
Urea was estimated by an enzymatic colorimetric method according 
to Zawada et al. [24]. The creatinine assay is based on the reaction of 
creatinine with sodium picrate according to Han et al. [25].
Estimation of LDL-cholesterol and triglycerides
Cholesterol was estimated by the CHOD-PAP-enzymatic colorimetric 
method according to Muralikrishna and Nirmala [26]. Triglycerides 
were estimated by the GPO-PAP-enzymatic colorimetric method 
according to Hansen et al. [27].
Tissue separation
After sacrifice, specimens from the pancreas, liver, and kidney were 
taken quickly. Samples were then carefully cut into small pieces for 
further examination.
Biochemical analyses
Tissues were kept frozen at −80°C and then homogenized using a tissue 
homogenizer Virtiz T-25 Polytronin ice-cold buffer. The homogenates 
(10% w/v) were prepared using phosphate buffer (pH 7.0) and were 
centrifuged at 5000 r. p. m. for 1 h at 4°C. The supernatant was used for 
the following assays:
Lipid peroxidation product (MDA)
MDA was assayed in tissue homogenates according to the method of 
Ekinci-Akdemir et al. [28]. Then, 200 µL of the samples was added 
to 1 ml of solution (Thiobarbituric acid 25 Mm/L, detergent, and 
stabilizer). These tubes were covered with glass beads, heated in a 
boiling water bath for 30 min, cooled and measured at 534 nm against 
a blank in the presence of a standard.
Superoxide dismutase activity
SOD was assayed in tissue homogenates according to the method of 
Basu et al. [29]. 100 µL of the sample were added to 1 ml of working 
solution (phosphate buffer + Nitro blue tetrazolium + NADH in a ratio of 
10 + 1 + 1 ml) and mixed well. The reaction was initiated by the addition 
of 0.1 ml of phenazine methosulfate, and the increase in absorbance 
was measured at 560 nm for 5 min for the control (Acontrol) and the 
sample (Asample) at 25°C.
Catalase activity
CAT was assayed in tissue homogenates according to the method of 
Sandalio et al. [30]. 5 µL of the sample were added to 0.5 ml phosphate 
buffer, pH7.0, and 0.5 ml H2O2. The mixture was incubated for 1 min at 
25°C, and a chromogen-inhibitor and peroxidase 4-aminoantipyrine 
preservatives were added. The solution was then incubated for 10 min at 
37°C and measured at 510 nm against a blank in the presence of a standard.
Glutathione peroxidase activity
GPx was assayed in tissue homogenate according to the method of 
Alam et al. [31]. 10 µL of the sample was added to 1 ml buffer, 100 µL 
NADPH and 100 µL H2O2. The solution was mixed well, and then the 




Pieces of the selected organs were collected from all groups, washed 
in sterile saline and kept in 10% neutral phosphate-buffered formalin 
(pH 7.0). For microscopic preparations, specimens were dehydrated in 
a graded ethyl alcohol series (50%–99%), cleared in methyl benzoate 
and embedded in molten paraffin wax at 58°C–62°C. Tissue sections 
were prepared at a 5 µm thickness and stained with hematoxylin and 
eosin [32] for microscopic investigation. Examination of the organ 
section to assess histological and histopathological alterations was 
performed under high-power light microscopy (Olympus BX43F, Tokyo 
163-0914, Japan). Image analysis was performed using a personal 
computer, a camera, software (Olympus DP74 Tokyo 163-0914, Japan) 
and an optical microscope.
Electron microscopy
For ultrastructural examination, the samples were processed, 
examined, and photographed in the Electron Microscopy Unit at Assiut 
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University. Small pieces of the selected organs were immediately 
immersed in a 4F1G/phosphate buffer (pH 7.2) fixation mixture for 3 h 
at 4°C and then postfixed in 1% OsO4 (osmium tetroxide) at 4°C for 2 h. 
The specimens were dehydrated in a graded series of ethanol and then 
embedded in Epon-araldite mixture in labeled beam capsules. An LKB 
ultramicrotome was used to obtain ultrathin sections (50 nm thick) 
that were picked on 200 mesh naked copper grids. Grids were double 
stained with uranyl acetate for 30 min and lead citrate for 20–30 min. 
The grids were examined using a TEM 100 CXII electron microscope at 
80 KV and photographed using a CCD digital camera Model XR-41.
Statistical analysis
Data are expressed as the mean ± standard deviation The differences 
between means were tested by one-way analysis of variance followed 
by the Student’s – Newman–Keuls t-test using Minitab 12 software. 
p <  0.05 was considered to indicate significance.
RESULTS
Estimation of changes in serum insulin, glucose, AST, ALT, urea, 
creatinine, LDL-cholesterol, and triglycerides
Table 1 shows that compared with the control group, the AV-group 
showed nonsignificant (p > 0.05) changes in the levels of all estimated 
serum parameters, while the STZ group showed a significant (p < 0.05) 
increase in the levels of glucose, triglycerides, LDL-cholesterol, AST, ALT, 
urea, and creatinine and a significant (p < 0.05) decrease in the level of 
insulin. Administration of AV to STZ-treated rats in both the ameliorative 
and protective groups induced a highly significant (p < 0.01) decrease 
in the levels of glucose, triglycerides, LDL-cholesterol, AST, ALT, urea, 
and creatinine and induced a highly significant (p < 0.01) increase in 
the serum insulin level.
Estimation of malondialdehyde (MDA) and antioxidant enzyme 
activity
Information about the effect of AV gel extract on the concentration of 
MDA and the activity of antioxidant enzymes in the selected tissues 
of the control and treated groups are presented in Table 2. Again, 
the AV-group showed non-significant (p > 0.05) changes in the MDA 
concentration and the activity of SOD, CAT, and GPx.
On the other hand, the STZ group exhibited a significant (p < 0.05) 
increase in the MDA concentration and a significant (p < 0.05) decrease 
in the activity of SOD, CAT, and GPx. Administration of AV to STZ-treated 
rats in both the ameliorative and protective groups induced a highly 
significant (p < 0.01) decrease in MDA and a highly significant (p < 0.01) 
increase in SOD, CAT, and GPx activity.
Histological studies
Pancreas
The effect of AV gel extract treatment on histological changes in the 
pancreatic tissues of the control and treated groups is shown in Figs. 1 
and 2. The pancreas of normal animals (Fig. 1a) and AV-group (Fig. 1b) 
showed normal pancreatic tissue structure, islets of Langerhans, and 
surrounding pancreatic acini. In contrast, the pancreas of the STZ group 
(Fig. 1c) exhibited atrophied islets of Langerhans with degenerated 
cells of Langerhans. In the ameliorative (Fig. 1d) and protective (Fig. 1e) 
groups, we observed that the pancreas retained a healthy pattern and 
that the islets of Langerhans and surrounding pancreatic acini were 
normal to a large extent.
Beta cells were identified by their characteristic secretory granules 
in the normal group (Fig. 2a) and AV-group (Fig. 2b). The secretory 
granules had an electron-dense core of variable electron density (light 
and dark granules) surrounded by an electron-lucent halo under the 
limiting membrane. The mitochondria were scattered throughout the 
cytoplasm. Ultrastructure examination of the beta cells of the STZ-
group showed degenerative alterations, which were represented by 
atrophied nuclei with ruptured nuclear membranes. The mitochondria 
appeared with electron lucent matrices and disorganization of some 
Golgi complexes. Moreover, fewer secretory granules were empty and 
had cytoplasmic vacuoles (Fig. 2c). Administration of AV to STZ-treated 
Table 1: Changes in serum insulin, glucose, ALT, AST, urea, creatinine, low-density lipoprotein-cholesterol, and triglycerides
Parameters Normal group AV-group Diabetic group Ameliorative group Protective group
Insulin (ng/dl) 2.07±0.82 2.096±0.86# 0.33±0.10* 0.88±0.55** 0.84±0.32**
Glucose (gm/dl) 205.80±1.85 201.68±1.85# 326.40±1.80* 268.50±1.80** 268.80±1.37**
Triglycerides (mg/dl) 5.96±0.44 5.95±0.37# 8.56±2.03* 3.07±0.80** 3.12±1.02**
LDL-C (mg/dl) 62.2±2.33 58.68±2.08# 94.45±2.37* 57.52±2.31** 64.36±2.42**
ALT (U/I) 31.5±1.71 30.74±1.75# 68.2±1.20* 38.10±1.78** 39.20±1.51**
AST (U/I) 58.1±1.71 57.97±1.67# 80.7±1.32* 56.30±1.78** 60.80±1.51**
Urea (mg/dI) 20.44±2.10 18.76±2.97# 61.05±2.17* 28.06±2.67** 30.79±2.37**
Creatinine (mg/dl) 0.34±0.12 0.325±0.13# 2.07±0.82* 0.31±0.55** 0.31±0.33**
Values are means±SD of 10 animals in each group. #Nonsignificant (p>0.05) compared to control group. *Significant (p< 0.05) compared to control group. 
**Highly (p< 0.01) significant compared to diabetic group. LDL-C: Low-density lipoprotein-cholesterol, AST: Aspartate transaminase, ALT: Alanine transaminase, 
AV: Aloe vera, SD: Standard deviation
Table 2: The effects of Aloe vera extract on peroxidation and tissue antioxidants level in streptozotocin-induced diabetic rats
Parameters Tissue type Normal group AV-group Diabetic group Ameliorative group Protective group
MDA Pancreas 4.36±2.93 3.76±2.86# 10.86±2.90* 4.97±2.20** 4.70±2.76**
Liver 4.24±2.09 3.96±2.76# 10.56±2.97* 5.82±2.32** 4.87±2.49**
Kidney 5.60±2.39 4.57±2.86# 11.97±3.90* 4.13±2.16** 4.14±3.04**
SOD Pancreas 4.68±1.62 5.75±2.56# 4.26±2.23* 7.02±2.39** 6.66±2.31**
Liver 10.55±2.91 11.76±2.87# 3.55±1.59* 10.97±2.16** 7.84±2.39**
Kidney 7.52±2.44 7.66±2.86# 4.86±2.90* 7.56±2.55** 6.75±2.52**
CAT Pancreas 86.90±1.96 90.67±2.87# 49.10±1.42* 74.40±2.08** 74.10±1.38**
Liver 64.41±1.03 70.57±1.86# 29.00±1.09* 79.60±1.98** 82.00±1.85**
Kidney 56.20±1.01 58.76±2.97# 46.20±1.77* 100.2±1.83** 74.20±1.10**
GPx Pancreas 5.68±1.54 5.96±1.57# 5.54±1.34* 7.99±2.20** 7.82±1.88**
Liver 6.47±1.48 6.85±1.78# 5.45±1.50* 8.15±2.05** 7.77±1.87**
Kidney 5.46±1.48 5.86±1.67# 5.39±1.42* 7.92±2.19** 7.68±1.80**
Values are means±SD of 10 animals in each group. #Nonsignificant (p> 0.05) compared to control group, *Significant (p< 0.05) compared to control group, 
**Highly (p< 0.01) significant compared to diabetic group. AV: Aloe vera, SD: Standard deviation, MDA: Malondialdehyde, SOD: Superoxide dismutase, CAT: Catalase, 
GPx: Glutathione peroxidase
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rats (ameliorative and protective groups) revealed improvements in 
islet structure, including the disappearance of cytoplasmic vacuoles 
due to the regeneration of cytoplasmic content and cytoplasmic 
organelles, such as the rough endoplasmic reticulum, Golgi complex, 
and mitochondria (Fig. 2d and e, respectively).
Liver
Sections of liver from control animals (Fig. 3a) and AV-treated 
animals (Fig. 3b) showed normal architecture with normal hepatic 
cords composed of hepatocytes and healthy central veins as well as 
blood sinusoids. The majority of hepatocytes displayed eosinophilic 
cytoplasm with vesicular nuclei. In the STZ group, the liver showed 
marked pathological changes as evidenced by extensive cell necrosis 
with pyknotic nuclei. In addition, obvious congestion of the central 
vein and blood sinusoids is shown in Fig. 3c. STZ-treated rats in 
both the ameliorative and protective groups that were administered 
AV showed the good and normal appearance of hepatocytes as well 
as central veins and blood sinusoids to a large extent (Figs. 3d and e, 
respectively).
In the electron microscopic analysis, hepatocytes of control (Fig. 4a) 
and AV-treated animals (Fig. 4b) displayed normal structures and a 
healthy appearance. Electron micrographs of hepatic cells from the STZ 
group (Fig. 4c) showed obvious alterations, such as degenerated nuclei 
with disintegrated chromatin and an irregular envelope. In addition, 
cytoplasmic vacuoles, many lysosomes, and mitochondria with 
damaged cristae were noticed. Electron micrographs of hepatocytes 
from both the ameliorative and protective groups revealed no ultra-
pathological impairments compared with those of the diabetic group 
(Fig. 4d and e, respectively).
Kidney
Sections of normal kidneys (Fig. 5a) and AV-treated animals (Fig. 5b) 
showed healthy cortex with normal Malpighian corpuscles and renal 
tubules. Kidney sections from the STZ group showed deteriorated 
glomeruli in the Malpighian corpuscles and necrotic renal tubule cells 
with pyknotic nuclei (Fig. 5c). STZ-treated rats in both the ameliorative 
and protective groups showed nearly normal cellular architecture after 
AV administration (Fig. 5d and e, respectively).
Fig. 2: Electron micrographs of beta cells of control and treated 
groups. (a and b) Beta cells display euchromatic nuclei (N), the 
mitochondria (arrowhead) and secretory granules with light 
(thick arrow) and dark (thin arrow) cores. (c) Beta cell shows 
atrophied nuclei (AN) with rupture ( ) in nuclear membranes, 
and mitochondria (arrowhead) with electron lucent matrices and 
disorganization of some Golgi complexes ( ). Some secretory 
granules with very wide halos (arrow) and some cytoplasmic 
vacuoles (V) were noticed. (d) Beta cell reveals a nearly normal 
structure of rough endoplasmic reticulum ( ), Golgi complexes 
(G), scattered mitochondria (arrowhead), and secretory granules 
with light (thick arrow) and dark (thin arrow) cores. Note: 
Nuclei (N) retained ruptured nuclear membranes ( ). (e) Beta 
cell shows a more or less normal structure of nucleus (N) with 
nucleolus (n) and secretory granules with light (thick arrow) and 




Fig. 1: Pancreatic sections of the control and treated groups. 
(a and b) Pancreatic sections exhibit closely packed lobules of 
pancreatic acini (A) around the pale stained Islets of Langerhans 
(I). (c) Diabetic pancreas section displays pathological changes in 
the endocrine part of the pancreas represented by degenerated 
Islets cells (arrowhead). (d and e) Pancreatic sections have a 
more or less normal appearance of the Islets of Langerhans 
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Electron micrographs from proximal convoluted tubule lining cells of 
the normal group (Fig. 6a) and AV-treated group (Fig. 6b) exhibited a 
normal organization of the renal tubular lining cells. The ultrastructural 
findings of the STZ group showed marked intoxication of the renal 
tubules with severe degenerative alterations in the nuclei manifested 
by atrophy of some nuclei and by deformation of the nuclear membrane 
of other nuclei (Fig. 6c). Again, STZ-treated rats in both the ameliorative 
and protective groups administered AV showed nearly normal cellular 
architecture, with relatively normal-appearing basal mitochondria and 
nucleus with nucleolus. In addition, some electron-dense cytoplasmic 
bodies were apparent in the cytoplasm of the cell (Fig. 6d and e, 
respectively).
DISCUSSION
Our data from the current work clearly confirm the antioxidative 
potential of AV extract in the amelioration of diabetes mellitus-
induced oxidative damage in the pancreas, liver, and kidney of rats and 
changes in other diabetes-related indicators, such as serum insulin, 
glucose, triglyceride, LDL-cholesterol, AST, ALT, urea, and creatinine. 
The antidiabetic effects of AV were supported by its antioxidative 
properties, as evidenced by a decrease in tissue LPO and an increase 
in cellular antioxidants, such as SOD, CAT, and GPx. Diabetes mellitus 
is a chronic disease characterized by metabolic disturbances, and its 
problems include hyperglycemia and hypoinsulinemia [14,33-35]. STZ 
is widely used in experiments to induce a diabetic model due to its 
ability to cause β-cell toxicity in mammals [36]. The significant indices 
in the pathogenesis of diabetes are pancreatic dysfunction and cell 
death [37-39]. STZ induces diabetes by creating reactive oxygen species 
and decreasing antioxidant capacity, hence causing cytotoxicity in 
pancreatic beta cells [40]. The oxidative stress following STZ treatment 
in the current research is in agreement with previous studies [33, 40]. 
In addition, our results postulated that the histological results of the 
pancreas confirmed the ameliorative and protective effect of AV extract 
in pancreatic tissues. While as in previous studies [41], STZ-treated 
pancreatic tissues exhibited atrophied islets of Langerhans with 
degenerated islet cells, AV administration to STZ-treated rats revealed 
a specific degree of recovery in the cell morphology of the influenced 
islet cells that closely resembled the ordinary cell morphology of the 
islet of Langerhans. Interestingly, treatment with AV extract noticeably 
reduced the STZ-induced increase in serum glucose and lipids as 
well as tissue LPO but increased the levels of antioxidants and serum 
insulin. The tissue activities of SOD, CAT, and GPx were also enhanced, 
suggesting the antioxidative potential of the AV extract. The current 
study demonstrated the antioxidant effect of AV extract on both normal 
and diabetic rats. Treatment for 21 days revealed no adverse effects and 
no significant alterations in the status of tissue LPO, antioxidants, serum 
Fig. 4: Electron micrographs of the rat hepatocytes of control and 
treated groups. (a and b) Hepatocytes reveal normal structure 
of rounded nuclei (N), nucleoli (star), numerous mitochondria 
(arrowhead), cisternae of rough endoplasmic reticulum (thick 
arrow), and glycogen granules (thin arrow). (c) Hepatic cell 
displays degenerated nuclei (DN) with disintegrated chromatin and 
irregular envelopes ( ). Cytoplasmic vacuoles ( ), lysosomes 
( ), and mitochondria with damaged cristae (arrowhead) were 
noticed. (d and e): Hepatic cells exhibit more or less similarity to 





eFig. 3: Liver sections of the control and treated groups. 
(a and b) Liver sections exhibit normal hepatic cords of 
hepatocytes (h), central vein (CV) and between the cords of 
hepatocytes, blood sinusoids (S) are often seen. (c) Diabetic liver 
section manifests pyknotic nuclei (arrow). Noticeable congestion 
of the central vein (Cong) and blood sinusoids (arrowhead) were 
also seen. (d and e) Liver sections show near-normality of cords 
of hepatocytes (h), blood sinusoids (S), and central vein (CV). 
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insulin, glucose, or lipids compared to control animals and displayed 
positive effects reflected in the diabetic animals with respect to other 
indices, such as serum glucose, insulin, triglyceride, LDL-cholesterol, 
AST, ALT, urea, and creatinine.
The recorded increase in serum glucose in diabetic animals may be 
caused by oxidative stress in the liver [42], where a marked increase 
in oxidative stress was detected as proved by a significant increase in 
hepatic LPO. Our findings reinforced those of previous authors, such 
an antioxidant effect of AV extract on experimental animals [43,44]. 
In the present study, AV treatment reduced the LPO in all three types 
of tissues. Moreover, our results are in according with Mohapatra 
et al. [14] and Gabriel et al. [43], confirming that the AV-supplemented 
diet increased SOD, CAT, and GPx activity and decreased MDA activity 
in plasma. The antioxidant activity of AV extract may be attributed 
to the opinion of Goda [44], who mentioned that the improvement 
of antioxidant activities by medicinal herbs is due to their abundant 
bioactive compounds. In addition, the majority of phenol/polyphenols, 
alkaloids, enzymes (SOD, CAT, and GPx), vitamins (ascorbic acid), and 
polysaccharides present in Aloe leaves are known to possess antioxidant 
activity, with high levels of oxygen free radical scavengers [45]. In 
addition, our result was similar to the findings of Rajasekaran et al. [46] 
and Nwajo [47] and Abo-Youssef and Messiha [48], who found that AV 
supplementation reversed the altered oxidative stress parameters, 
repressing elevated serum MDA levels and increasing blood GSH and 
SOD levels. Many explanations have been suggested for this antioxidant 
effect of AV extract. Of these, AV has long been known to have 
antioxidant potential through repression of free radical formation and 
enhancement of cellular thiol status [49-52].
Indeed, liver and kidney are represented as major target organs for 
drugs [53]. In the current work, in addition to pancreatic damage, STZ 
administration led to hepatic damage causing hepatic malfunction and 
alterations in the circulating concentrations of hepatic damage enzymes. 
Monitoring the levels of serum ALT and AST, which are also sensitive 
serological indicators of hepatotoxicity, are indicative of a clinical diagnosis 
of the disease and damage to the structural integrity of liver [54,55]. 
Oxidative stress related to STZ-induced diabetes has been found in response 
to higher levels of these enzymes in serum [53], as also found in our study, 
confirming that STZ administration induced liver tissue damage and 
significant elevation in serum ALT and AST levels. Again, AV administration 
to animals treated with STZ reduced these two marker enzymes, which 
was also reinforced by histological examination and revealed a significant 
improvement in liver histological damage in the STZ-treated group. Similar 
effects of various other medicinal plants have been observed [39].
Fig. 6: Electron micrographs of the proximal tubule lining cells 
of control and treated groups. (a and b) Normal appearance of 
proximal tubule lining cells with brush borders (BB), nuclei 
(N), nucleoli (*), mitochondria (m), and infoldings of the basal 
membrane (arrow). (c) The proximal tubule lining cell shows a 
ruptured brush border ( ), abnormally shaped nucleus (thick 
arrow), and an atrophied nucleus (arrowhead). (d and e) The 
proximal tubule lining cells reveal a normally shaped nucleus 
(N), nucleolus (*), mitochondria (m), and infoldings of the basal 
membrane (arrow) and brush border (BB). Dense cytoplasmic 





Fig. 5: Kidney sections of the control and treated groups. (a and b) 
Kidney sections exhibit normal appearance of the Malpighian 
corpuscle (G), and distal (arrowhead) and proximal (arrow) 
convoluted tubules. (c) Diabetic kidney section shows necrosis 
of tubular cells (arrow), atrophy of the glomeruli (arrowhead) 
and necrotic areas (*). (d and e) Kidney sections display nearly 
normal Malpighian corpuscle (G), and distal (arrowhead) and 
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The ambient blood glucose level in STZ-treated rats induces a stable 
increase in the levels of serum urea and creatinine, which are standard 
markers of renal dysfunction [56-58], as also found in our study. 
However, these alterations might be due to metabolic disturbances 
during diabetes by an elevation in the levels of triglycerides and 
cholesterol. Surprisingly, AV administration to STZ-treated rats in 
both the ameliorative and protective groups resulted in a reduction 
in the levels of urea and creatinine compared to those of STZ-treated 
animals, again suggesting the ameliorative and protective effects 
of AV extraction kidney tissues. Moreover, the histological pictures 
of STZ-treated kidneys displayed marked histological changes. The 
histological evaluation illustrated that AV administration motivated 
improvement in histopathological changes to near-normal morphology. 
Thus, AV extract produced a renal-protective effect at the functional and 
tissue levels. However, AV administration decreased not only glucose 
but also the levels of cholesterol and triglycerides. This decrease in 
cholesterol and triglyceride levels by AV administration to STZ-treated 
rats is also similar to that in earlier reports [59, 60]. As hyperlipidemia 
has been confirmed to be ameliorated by the administration of 
antioxidants [61-63], it may be assumed that in our study, AV, being a 
strong antioxidant, reversed hyperlipidemia through its antioxidative 
potential. Thus, our study clearly suggests that AV extract has the 
potential to ameliorate and protect against hyperlipidemia in STZ-
induced diabetic rats.
CONCLUSION
Our data obtained from the present study confirmed that all STZ-induced 
adverse effects were reversed by the simultaneous administration of AV 
extract through its antioxidative potential. Thus, the AV extract has a 
protective and ameliorative potential against diabetes mellitus through 
its antioxidant and antidiabetic potency. In addition, these findings are 
promising for further clinical examination of the effects of AV extract or 
ingredients of extraction diabetes mellitus.
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